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In erythrocytes, the regulation of the redox sensitive Tyr phosphorylation of band 3 and its functions are still partially defined. A
role of band 3 oxidation in regulating its own phosphorylation has been previously suggested.The current study provides evidences
to support this hypothesis: (i) in intact erythrocytes, at 2mM concentration of GSH, band 3 oxidation, and phosphorylation, Syk
translocation to the membrane and Syk phosphorylation responded to the same micromolar concentrations of oxidants showing
identical temporal variations; (ii) the Cys residues located in the band 3 cytoplasmic domain are 20-fold more reactive than GSH;
(iii) disulfide linked band 3 cytoplasmic domain docks Syk kinase; (iv) protein Tyr phosphatases are poorly inhibited at oxidant
concentrations leading to massive band 3 oxidation and phosphorylation. We also observed that hemichromes binding to band
3 determined its irreversible oxidation and phosphorylation, progressive hemolysis, and serine hyperphosphorylation of different
cytoskeleton proteins. Syk inhibitor suppressed the phosphorylation of band 3 also preventing serine phosphorylation changes and
hemolysis. Our data suggest that band 3 acts as redox sensor regulating its own phosphorylation and that hemichromes leading to
the protracted phosphorylation of band 3 may trigger a cascade of events finally leading to hemolysis.
1. Introduction
Due to their function in carrying oxygen and their high
iron content, red blood cells (RBCs) are constantly exposed
to oxidative stress [1]. In addition, RBCs may transiently
experience oxidative stress when they are exposed to ROS
crossing inflammatory tissues or interacting with oxidant
contained in drugs or foods [2–4]. Moreover, a number of
hemolytic disorders are also known to damage the RBC
membrane increasing the production of free radicals origi-
nating from denatured hemoglobin species (hemichromes),
invariably present in thalassemia, sickle cell disease [5–7]
or with decreased ability of RBCs to deal with extracellular
oxidants as in G6PD deficiency [8].
It is noteworthy that approximately 7% of world popula-
tion is affected by those mutations which have been selected
by malaria.
It is well known that RBCs respond to oxidative stress
with a metabolic response finalized to maximize the pro-
duction of NADPH and to regenerate the stores of GSH
and thioredoxin. In parallel, RBCs also respond by activating
tyrosine kinases determining the tyrosine (Tyr) phosphory-
lation of band 3, the most abundant RBC membrane protein
and the major linkage between the cytoskeleton and the lipid
bilayer [9–12]. In RBCs, hyperphosphorylation of band 3
has been constantly reported in all the prooxidant hemolytic
disorders [13–15] and in malaria [16, 17], but the mechanisms
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leading to its phosphorylation and its pathophysiological sig-
nificance have been partially defined. We recently described
that band 3 phosphorylation appears to be increased in
intermediate thalassemia [18] and that this phenomenon is
closely related to the formation of hemichromes. Band 3
phosphorylation and hemichromes formation have been also
described in malaria infected RBC [19]. In both patholog-
ical situations, band 3 phosphorylation appears to play a
permissive role in the release of membrane microparticles.
Current knowledge appears to be still insufficient to explain
the molecular details of the underlying mechanism, although
some recent findings clearly indicate a role of band 3 phos-
phorylation in the regulation of metabolism mediated by the
binding of deoxygenated hemoglobin (Hb) [20–22] and in
the modification of the affinity between band 3 and ankyrin
following oxidative stress [23].
The redox regulation of band 3 Tyr phosphorylation
apparently involves different components. In a previous
report, it has been demonstrated that oxidized band 3 is selec-
tively phosphorylated [9]. Lyn is responsible for the phospho-
rylation of Tyr 359 and Syk is responsible for the phosphory-
lation of Tyr 8 and Tyr 21 [24–26]. Interestingly, all of those
residues are located in the cytoplasmic domain of band 3.
Phosphatases (PTPs) have also been implicated in the
phosphorylation of band 3 that follows oxidative stress [27–
29] and inhibition of PTPs is due to the inhibitory Cys residue
present in the catalytic site of some PTPs but the reactivity
to H
2
O
2
of the inhibitory Cys is 0.005-fold lower than GSH,
indicating that, at its normal concentrations, GSH should
very effectively protect PTPs from oxidative inhibition [30,
31]. Additional regulatory components could be also involved
in the band 3 phosphorylation: Lyn kinase has been described
to act as redox sensor [32]; Lyn activates Syk in different
cell types and the role of Syk autophosphorylation remains
to be elucidated [25, 26]. Moreover, all of those regulations
have been mainly studied in immune cells and very little
information is available on RBCs.
In the present report we performed a series of experi-
ments to gain more information on the mechanisms that are
involved in the Tyr phosphorylation of band 3 following a
reversible membrane protein oxidation triggered by diamide
and H
2
O
2
and by hemichromes which cause irreversible
oxidation.
2. Materials and Methods
2.1. Treatment of Red Blood Cells. Venous blood was drawn
from healthy volunteers following informed consent and
pelleted at 1000 g for 10 minutes at room temperature. After
removal of the buffy coat, RBCs were again pelleted and
washed 3 times with phosphate buffered saline (127mM
NaCl, 2.7mM KCl, 8.1mM Na
2
HPO
4
, 1.5mM KH
2
PO
4
,
20mM HEPES, 1mM MgCl
2
, and pH 7.4) in 5mM glucose
(PBS glucose) to obtain packed cells. RBCs were suspended
at 20% hematocrit in PBS glucose and incubated at 37∘C
in 0.5mM diamide at different incubation times (0, 30,
60, 120, 240, and 360 minutes) and then in the presence
of different diamide concentrations. Separate experiments
were also performed in 5mM H
2
O
2
or 1mM phenylhy-
drazine (PHZ). pH was measured after 180 minutes and
adjusted to 7.4 with NaOH.When necessary to avoid tyrosine
phosphorylation, RBCs were pretreated with 10 𝜇M of Syk
inhibitor II (Calbiochem, USA), for 1 hour at 37∘C in the
dark, before oxidant treatment. For all protocols described,
untreated controls were processed identically except that the
inhibitorwas omitted from the incubation. To prevent further
phosphorylation of band 3, after incubation we washed the
cells with cold buffer and membranes were immediately
prepared.
2.2. RBC Membrane Preparation. Membrane proteins were
prepared at 4∘C on ice as previously described [9]. Briefly,
150 𝜇L of packed RBCs was diluted into 1.5mL of cold hemol-
ysis buffer (HB) (5mM sodium phosphate, 1mM EDTA, pH
8) containing a protease and a phosphatase inhibitor cocktail
and then washed up to 4 more times in the same buffer
(until membranes became white) in a refrigerated Eppendorf
microfuge at 25000 g. The preparations were stored frozen at
−80∘C until use. Membrane protein content was quantified
using the CD Protein Assay (Bio-Rad).
2.3. SDS-PAGE. To perform one-dimensional electrophore-
sis, membrane proteins were solubilized in Laemmli Buffer
[33] in a volume ratio of 1 : 1. 10 𝜇g of proteins for ana-
lytical gels, 1 𝜇g of proteins for anti-band 3, and 30𝜇g of
proteins for anti-phosphotyrosine, anti-phosphoserine, and
anti-Syk antibodies were loaded for western blot analysis and
separated on 8% of polyacrylamide gel under reducing and
nonreducing conditions. SDS-PAGE analysis was conducted
by heating the sample for 5 minutes at 95∘C and was run on
the Bio-Rad mini-protean 3 setup.
2.4. Western Blot Analysis. Proteins separated by SDS-PAGE
were transferred to nitrocellulose membranes as previously
described [16] and then probed with 5 different anti-
bodies: monoclonal anti-band 3 antibody (B9277, Sigma-
Aldrich, Saint Louis, MO) produced in mouse (directed to
cdbd3) diluted to 1 : 50000; anti-phosphotyrosine (sc7020,
Santa Cruz, CA); anti-phosphoserine (ab9332, Abcam, Cam-
bridge, UK); polyclonal anti-band 3 (sc20657); and anti-
Syk (sc28337). The final two produced in rabbit from Santa
Cruz, CA, all are diluted to 1 : 2000. Secondary antibodies
conjugated to infrared fluorescent dyes excitable at 680 nm or
800 nm (IRDye: anti-mouse 800CW 926-32210, anti-mouse
680CW 926-32220, and anti-rabbit 800CW 926-32211, Li-
COR, USA) were then used to visualize the desired antigens
with a laser scanner (Odyssey, Licor, USA). Quantitative
densitometry study of tyrosine phosphorylation was carried
out, and Syk translocation and band 3 oxidation levels were
measured analyzing western blot images by the Odyssey V3.0
software, and values were expressed as arbitrary units.
2.5. Measurement of Band 3 SH-Groups Reactivity in the
Presence of Increasing GSH Concentrations. RBCmembranes
were diluted in HB to obtain a 5 𝜇M band 3 concentra-
tion. Band 3 concentration was estimated measuring total
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membrane proteins in packed membranes (approximately
4mg/mL) considering that band 3 represents approximately
25% of total membrane proteins and a band 3M.W. of
95.000Da. Resuspended membranes were incubated for 10
minutes on ice, with 0.1mM diamide in the presence of
increasing concentrations of GSH. The reaction was stopped
by washing the solution 3 times with HB. The percentage
of oxidized band 3 was evaluated by western blot following
nonreducing 8% SDS-PAGE and expressed as percentage of
the maximal oxidation measured in the absence of GSH. In
the absence of GSH an average of 95.2 ± 4.5% of the band
3 was found present in reducible aggregates with a M.W.
>200.000KDa.
2.6. PTP Activity Measurement. Erythrocyte PTP activity
was measured using phosphorylated band 3 as substrate.
Phosphorylated band 3 was obtained treating RBCs with
1mM diamide. Membranes were prepared and incubated for
10min at 37∘C with the cytoplasmic fraction of RBCs treated
with different concentrations of diamide. 10𝜇MSyk inhibitor
II (Calbiochem, USA) was added to prevent further phos-
phorylation of band 3. The rate of band 3 dephosphorylation
was expressed as PTP activity and as a percentage of maximal
activity in untreated RBCs.
2.7. Hemoglobin Release Quantification. We used a simplified
method to measure the relative changes of Hb in RBC
cultures supernatant; after discarding RBC membranes by
centrifugation, lysis was quantified bymeasuring hemoglobin
absorbance at 405 nm in RBC supernatant and expressed in
nmoles/mL [34].
2.8. Hemichrome Measurement. RBCs were solubilized in
HB containing 1% Triton X-100, centrifuged at 15.000 g at
4∘C. High molecular weight hemichrome aggregates were
separated from the supernatant on a Sepharose CL-6B
microcolumn. The hemichrome fraction was then diluted
and quantified measuring heme absorbance at 560, 577, and
630 nm [35] and expressed as nmoles/mL of solubilized
membranes.
2.9. Immunoprecipitation Studies. RBC membrane proteins
were treated in the presence or the absence of 2mM diamide,
solubilized for 10 minutes on ice with 3 volumes of 1% Triton
X-100 inHB. After centrifugation in a refrigerated Eppendorf
microfuge at 15000 g, supernatants were collected and incu-
bated with anti-mouse anti-band 3 cross-linked to Protein A-
Sepharose (1 : 10) via bifunctional coupling reagent dimethyl
pimelimidate for 2 hours at 4∘C under gentle mixing. Beads
were washed three times with 1% Triton X-100 in HB [9].
Laemmli buffer, containing 2% DTT (final concentrations),
was added to packed beads (2 vol) and immunoprecipitated
proteins were analyzed by immunoblotting using anti-band 3
and anti-Syk antibodies.
2.10. Cytoplasmic Domain of Band 3 Fragment Phosphory-
lation in Reconstituted Systems. To obtain the oxidized and
nonoxidized cdbd3 fragment, RBCs were incubated with
or without diamide (2mM). Membranes were prepared as
described above and cytoskeletal proteins were eliminated
incubating themembranes with 0.1MNaOH at 4∘C (stripped
membranes). Cdbd3was then purified fromRBCmembranes
as previously described [36]. The purity of cdbd3 was higher
than 90%. After diamide treatment more than 60% of cdbd3
was present as disulfide cross-linked dimers. To measure
band 3 phosphorylation in the presence of soluble oxidized
and nonoxidized cdbd3, RBC membranes were incubated at
37∘C for 10minuteswithRBCcytoplasm (diluted 1 : 10) as pre-
viously described [9]. The reaction was stopped by washing
the membranes with HB. Band 3 tyrosine phosphorylation
was then measured by western blotting as described above.
The association between Syk and cdbd3was tested incubating
oxidized and nonoxidized cdbd3 with RBC cytoplasm at
37∘C for 10 minutes and anti-band 3 immunoprecipitation
was followed by western blot using anti-Syk antibody diluted
1 : 100.
2.11. Peptide Preparation forMS Analysis. Bands were excised
from electrophoresis gels andwere destained by doing several
washes in 5mM NH
4
HCO
3
/ACN (acetonitrile) (50/50 v/v)
and successively dried with pure ACN. The gel slices were
rehydrated for 45minutes at 4∘C in 20𝜇L of 5mMNH
4
HCO
3
digestion buffer containing 10 ng/𝜇L of trypsin. Excess pro-
tease solution was removed and the volume was adjusted
with 5mM NH
4
HCO
3
to cover the gel slices. Digestion was
allowed to proceed overnight at 37∘C.
2.12. Peptide Mass Fingerprinting by MALDI-TOF MS. Sam-
ples were loaded onto MALDI target using 1𝜇L of the
tryptic digests mixed 1 : 1 with a solution of CHCA (alpha-
cyano-4-hydroxycinnamic acid) (10mg/mL in ACN/TFA
0.1%, 40/60). MS analysis of peptides from 1-DE gel bands
was performed with a MALDI-TOF micro MX (Micromass,
Manchester, UK) according to the tuning procedures sug-
gested by the manufacturer. Peak lists were generated with
ProteinlynxData Preparation using the following parameters:
external calibration with lock mass using mass 2465.1989Da
of ACTH fragment 18-39 background was subtracted using
the adaptive mode, performing deisotoping with a thresh-
old of 3%. The MS spectra were converted into pkl files
using Mass Lynx 4.0. Peak lists containing the 20 most
intense peaks of the spectrum were sent to MASCOT PMF
search (http://www.matrixscience.com/) using a Swiss-Prot
database (release 50.0, 30 May 2006). Search settings allowed
one missed cleavage with the trypsin enzyme to be selected,
carboxymethylated cysteine as fixed modification and oxi-
dation of methionine as potential variable modification and
a peptide tolerance of 50 ppm. Only protein identifications
with significant Mascot scores (𝑝 < 0.05) were taken in
consideration.
3. Results
3.1. Tyrosine and Serine Phosphorylative Response to Different
Oxidant Species. Time dependent phosphorylative changes
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Figure 1: Time course of erythrocyte membrane proteins treated with oxidants. Erythrocytes were treated with 0.5mM diamide (Dia)
(panels (a) and (b)) and with 1mM phenylhydrazine (PHZ) (panels (c) and (d)) at different incubation times. Membrane proteins were
separated by 8% SDS-PAGE in the presence of reducing agent, blotted on nitrocellulose and stained with anti-phosphotyrosine (apTyr)
and anti-phosphoserine (apSer) antibodies. Images were acquired using a laser IR fluorescence detector (Odyssey, Licor, USA). Results are
representative of 4 separated experiments.
of the RBCmembrane proteins have beenmeasured compar-
ing the effects of (i) diamide, a single electron oxidant that
induces disulfide formation [9, 26], (ii) hydrogen peroxide
(H
2
O
2
) that is physiologically generated from superoxide
anion during methaemoglobin formation and by denatured
hemoglobin products [37], and (iii) phenylhydrazine (PHZ)
that reacts specifically with hemoglobin determining the
formation of hemichromes which are capable of triggering
ROS production [38, 39].
Diamide caused an intense and transient Tyr phosphory-
lation of band 3 and of proteins 4.1 and 4.2 though to a lesser
extent and Ser phosphorylation changes in additional mem-
brane protein (Figures 1(a), 1(b), and 2 and Table 1). H
2
O
2
induced a phosphorylation response identical to diamide but
at 10-fold higher concentration (data not shown). This is
plausibly due to the potent scavenging activity of catalase and
glutathione peroxidase in RBCs on H
2
O
2
.
Conversely PHZ caused a slow phosphorylation response
measurable only after 60 minutes of incubation (Figures 1(c)
and 1(d)). Tyr phosphorylation of band 3 was one of the
earliest events but additional proteins were also phospho-
rylated at Tyr and Ser residues after 120–360 minutes of
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Figure 2: Protein phosphorylation analysis by mass spectrometry. Tyrosine phosphorylated proteins after 30-minute incubation of RBCs
with 0.5mM diamide (a) and serine phosphorylated proteins after 2-hour incubation of RBCs with 1mM PHZ (b). Phosphorylated proteins
were analyzed by mass spectrometry (MALDI-TOF) (Table 1). Band numbering in panels (a) and (b) identifies the proteins listed in Table 1.
Table 1
Band
number
Protein
name
Accession
number Phosphorylated peptide
1 Band 3 P02730
MEELQDDYED (Tyr 8)
YEDPDIPESQ (Tyr 21)
PAKPDSSFYK (Tyr 359)
2 Protein 4.1 P11171 VYECVVEKHA (Tyr 222)
3 Protein 4.2 P16452 Not identified
4 Catalase P04040 KVWPHKDYPL (Tyr 308)
5 P55 Q00013 AIRSQYAHYF (Tyr 429)
6 Actin P60709 GRDLTDYLMK (Tyr 188)
7 G3PDH P04406 PFIDLNYMVY (Tyr 42)
8 Betaspectrin P11277 ERTSPVSLW (Ser 2114)
9 Ankyrin P16157 DQVVESPAIP (Ser 856)
10 AlphaAdducin P35611 REKSKKYSDV (Ser 408)
11 BetaAdducin P35612 TPSFLKKSKK (Ser 713)
12 Protein 4.1 P11171 QEQYESTIGF (Ser 461)RHSNLMLEDL (Ser 664)
13 Protein 4.2 P16452 LLNKRRGSVP (Ser 248)
14 Catalase P04040 TFVQSGSHLA (Ser 517)
15 P55 Q00013 SCSPFGKKKK (Ser 243)
16 Actin P60709 ANTVLSGGTT (Ser 300)
17 G3PDH P04406 ISWYDNEFGY (Ser 312)
incubation.These data were also supported by the absence of
reactivity when the proteinswere treatedwith𝜆-phosphatase,
which was used to remove phosphate groups from blotted
proteins (data not shown). Control experiments to exclude a
direct oxidant effect of PHZ (2mM) on isolated membranes
revealed no effect on band 3 sulfhydryl groups (data not
shown). The lack of short term effects of PHZ on membrane
protein phosphorylation is coherent with its specific action
on hemoglobin and the slow formation of hemichromes
[38, 39]. A list of phosphorylated proteins, identified by
mass spectrometry, is shown in Figure 2 and Table 1. At
least one phosphorylation site has been identified on each
phosphoprotein with the exception of protein 4.2. It should
be noticed that similar protein phosphorylation patterns
have been previously observed in pathological situations
characterized by high content of hemicromes such asmalaria
infected RBCs, G6PD deficiency, and thalassemia [16, 18].
3.2. Functional Relationships between Band 3 Oxidation and
Its Tyr Phosphorylation. To obtain quantitative data on the
relationships intercurring between band 3 oxidation and its
Tyr phosphorylation, we performedparallelmeasurements of
the detection limits of band 3 phosphorylation (Figure 3(a))
and its oxidative crosslinking (Figure 3(b)) starting from
very low concentrations of diamide.This experiment revealed
that both events become measurable at the same diamide
concentration (10–25𝜇M) that, due to the buffering effect
of cellular GSH, are not expected to exert an effect on
protein thiols. We observed a dose-dependent increase of
the phosphorylation signal (Figure 3(c)) and of the binding
of Syk to the membrane (Figure 3(d)). Interestingly both
phenomena became detectable in the same concentration
range of diamide. Those data comprehensively indicate
that, as previously suggested [9], Syk acts preferentially
on oxidized band 3. To further investigate this hypothesis,
we tested if purified oxidized cdbd3 fragment may exert
a competitive inhibitory action on the phosphorylation of
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Figure 3: Band 3modifications and Syk activation following diamide treatment. RBCs were treated with increasing concentration of diamide
for 30 min in the presence or in the absence of 10 𝜇M Syk inhibitor II (Syk I.). Band 3 tyrosine phosphorylation (panel (a)). Band 3 oxidative
crosslinking (oxidized band 3, Dia) expressed as the amount of oligomeric band 3 (apparent M.W. higher than 200KDa) under nonreducing
conditions (panel (b)). Syk tyrosine phosphorylation measured in whole cellular extracts (panel (c)). Syk bound to the membranes (Syk
translocation) (panel (d)). Western blotting was quantified using an IR fluorescence detection scanner (Odyssey, Licor, USA). Images were
analyzed by Odyssey V3.0 software. Values are representative of 4 separated experiments and are expressed as arbitrary units (au); the bars
represent the standard deviations.
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Figure 4: Competitive effect of oxidized and nonoxidized cdbd3
on band 3 phosphorylation and its association with Syk. Band
3 Tyr phosphorylation was measured in membranes obtained
from diamide treated RBCs in the presence of RBC cytoplasm at
increasing concentration of oxidized or nonoxidized cdbd3. The
level of band 3 phosphorylation is displayed as percentage of its
maximal phosphorylation absence of cdbd3 (panel (a)). Nonoxi-
dized (−Dia) cdbd3 and oxidized (+Dia) cdbd3 were incubated with
RBC cytoplasm and immunoprecipitated by anti-cdbd3 antibody.
Immunoprecipitated proteins were western blotted with anti-band
3 (panel (a)) and anti-Syk antibody (panel (b)). Western blots are
representative of 4 separated experiments.
band 3. Figure 4(a) shows that oxidized cdbd3 exerts a dose-
dependent inhibitory effect on band 3 phosphorylation, while
nonoxidized cdbd3 fragment did not exert any measurable
effect. RBCmembranes containing oxidized band 3were used
as PTPs substrate; on the contrary, experiment performed
with purified band 3 provided unreproducible results possibly
indicating that the requirement of a specific quaternary
structure of oxidized band 3 is essential to allow the docking
of Syk. Immunoprecipitation studies confirmed that Syk
binds prevalently to the oxidized form of cdbd3 (5.8-fold
higher, 𝑝 < 0.01) while no significant difference has been
observed between the amount of cdbd3 immunoprecipitated
from oxidized and nonoxidized samples (Figure 4(b)).
3.3. Measurement of the Accessibility of the Band 3 Cys
Residues. The characteristic accessibility of the two cysteins
201 and 317 located in the cytoplasmic domain of band 3
has been already demonstrated [36]. To obtain quantitative
data on the relative accessibility of those Cys residues,
we measured the effect of diamide (100 𝜇M) in forming
band 3 (5 𝜇M) intermolecular disulfide bonds on increasing
concentrations of GSH. This experiment showed that at
0.1mM GSH concentration (20-fold higher than band 3)
approximately 40% of band 3 was still oxidized by diamide;
at 1mM GSH concentration (200-fold higher than band 3)
approximately 20% of band 3 was still oxidized (Figure 6(a)),
indicating much higher accessibility of the Cys residues
located in the cdbd3 than GSH. Those results are therefore
in agreement with the observed oxidation of band 3 with low
concentrations of diamide as the blood concentration of GSH
is approximately 1mM.Moreover, we have noticed that at low
concentrations of diamide (50–100 𝜇M) no oxidation of GSH
was detectable (data not shown).
3.4. Comparative Analysis of Syk Kinase and Protein Tyr
Phosphatase Activities following Sulfhydryl Group Oxidation.
Erythrocyte PTPs have been implicated in promoting the Tyr
phosphorylation of band 3 due to an inhibitory Cys residue
located in their catalytic domain [10, 40].
To rule out the possibility that diamide treatment, at
concentrations that induce band 3 phosphorylation, may also
determine a substantial inhibition of PTPs, we compared
the levels of band 3 phosphorylation and PTP inhibition
at different diamide concentrations. Figure 6(b) shows that,
after treating RBCs with 1mM diamide that causes a nearly
maximal band 3 phosphorylation, PTPs still display approx-
imately 70% of their maximal activity. This finding is in
agreement with the low reactivity of the regulatory Cys
residue of PTPs that has been previously reported [30].
3.5. Effect of Syk Inhibitors on the Membrane Destabilization
Induced by Phenylhydrazine . Differently from the effect
of diamide that caused reversible changes, after phenylhy-
drazine treatment, band 3 oxidation, and its phosphorylation,
Syk translocation to the membrane and its phosphoryla-
tion increased progressively, paralleling the generation of
hemichromes (Figure 5). Also in this case Syk inhibitors
markedly inhibited band 3 phosphorylation with no apparent
effect on band 3 oxidation and Syk translocation (Figures 3
and 5).
Interestingly, Figure 5(f) shows that phenylhydrazine
treatment causes a progressive leak of hemoglobin through
the membrane. Hemolysis was substantially suppressed by
Syk inhibitors indicating that irreversible band 3 phospho-
rylation may induce a progressive destabilization of the
membrane plausibly through the weakening of the linkages
between band 3 and cytoskeleton [23].
4. Discussion
RBCs rapidly react to oxidative stress through very intense
Tyr phosphorylation of band 3, their major integral mem-
brane protein. We previously found that the phosphorylation
of band 3 affects its interactions with the cytoskeleton
inducing membrane destabilization [23]. This phenomenon
appears to play a central role in the release of membrane
microparticles containing hemichromes from thalassemic
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Figure 5: Band 3 modifications, hemichrome formation, and hemolysis after phenylhydrazine treatment. Erythrocytes were treated with
1 mM phenylhydrazine (PHZ) at different incubation times in the presence or in the absence of Syk inhibitor II (Syk I.). Band 3 tyrosine
phosphorylation (panel (a)), oxidized band 3 (panel (b)), Syk phosphorylation (panel (c)), and Syk translocation (panel (d)) were quantified
acquiring anti-phosphotyrosine, anti-band 3, and anti-Syk western blots using an IR fluorescence detection scanner (Odyssey, Licor, USA)
and analyzing images with Odyssey V3.0 software. Values are the average of 5 separated experiments and are expressed as arbitrary units (au);
the bars represent the standard deviations. Hemichromes (HMC) were quantified by vis spectrometry (panel (e)), hemolysisby measuring
hemoglobin absorbance at 405 nm (panel (f)) and are expressed in nmoles/mL. ∗ indicates the minimal concentration or shorter incubation
time that determines a statistically significant change by Student’s 𝑡-test in comparison to the control sample (𝑝 < 0.01).
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Figure 6: Comparative analysis of Syk kinase and protein Tyr phosphatase activities following diamide treatment. Erythrocyte membranes
were treated with 0.1mM diamide in the presence of increasing concentrations of GSH. Band 3 oxidation (percentage of maximal
oxidation, in the absence of GSH) is showed in panel (a). Tyr kinase activity was measured as band 3 tyrosine phosphorylation at different
diamide concentrations and expressed as percentage of maximal phosphorylation. PTP activity was measured as dephosphorylation of Tyr
phosphorylated band 3 (obtained treating RBCs with 1mM diamide) and expressed as percentage of maximal PTP activity (panel (b)). Band
3 oxidation and phosphorylation were quantified by Odyssey V3.0 software. Values are average of 3 separated experiments; the bars represent
the standard deviations.
erythrocytes and appears to be involved in the action
mechanism of some prooxidant antimalarial compounds
[18, 41]. Denatured hemoglobin products (hemichromes) are
generated in senescent erythrocytes in numerous hemolytic
diseases [42] and in malaria [16]. They bind to the cdbd3 and
release iron in the membrane generating free radical species.
Therefore, hemichromes appear to be a sensible source of
redox stress under physiological conditions and in prooxi-
dant pathological conditions. The crystal structure of cdbd3
indicates a tight dimer formed by interlocking dimerization
arms of the two monomers. The Cys 201 residue in one sub-
unit and the Cys 317 residue of the paired subunit are at close
distance and can easily form intermolecular disulfide bonds
following moderate oxidative stress [36, 43] and following
the binding of hemichromes [18, 35]. No data are available
on the structural changes induced by this modification but
previous findings demonstrated an increased accessibility of
extracellular band 3 epitopes following the exposure to very
low concentration of oxidants and in senescent red cells [44–
46], suggesting that conformational modification may occur
following disulfide crosslinking of band 3.
Anyway, the involvement of Syk kinase of band 3 oxida-
tion and of all the major steps of the pathway such as the
mechanism of redox sensing, its transduction, the regulation
of Syk activation, and docking to band 3 need to be clarified to
envisage the physiological role of this intense redox response
characteristic of erythrocytes. To address those issues, the
present work has been performed to obtain a series of
quantitative data to study (i) the temporal and dose effects
of different physiological and nonphysiological oxidants in
eliciting the minimal band 3 and Syk modifications, (ii) the
role of disulfide cross-linked band 3 in docking Syk, (iii)
the buffering effect of GSH on the oxidation of band 3 Cys
residues to rule out if band 3 could display activity as redox
sensor in intact erythrocytes, and (iv) the relative roles of
Syk activation and docking versus PTPs inhibition in the
phosphorylation of band 3.
The presented results indicate that band 3 possess highly
reactive Cys residues capable of being easily oxidized in the
presence of physiological concentration of GSH and that
disulfide cross-linked band 3 docks Syk and acts as com-
petitive inhibitor of band 3 phosphorylation. Those results
support the observed changes in whole RBCs with very low
concentration of a specific sulfhydryl reagent (diamide) or
following the formation of minute amounts of hemichromes.
In both models band 3 phosphorylation exactly parallels its
oxidation. On the other hand erythrocytes seem to be fairly
protected by H
2
O
2
. The comparative measurement of band 3
phosphorylation and of PTPs inhibition at different concen-
trations of diamide revealed that intense phosphorylation can
occur at concentrations that minimally inhibit erythrocytes
PTPs acting on phospho-band 3.This finding is in accordance
with the relatively low reactivity of the Cys residue located
in the catalytic site of PTPs [30] and with the much higher
reactivity of the Cys residues located in the cdbd3.
In the present report, we observed that Syk inhibitors
are potent inhibitors of the hemolysis that follows to the
generation of hemichromes. Considering that treatment with
diamide or H
2
O
2
which induces a transient phosphorylation
of band 3 does not cause hemolysis, a persistent phospho-
rylation of band 3 induced by irreversible hemichromes
apparently leads to a severe membrane destabilization. It
should be anyway noticed that hemichromes formation
was also accompanied by serine phosphorylative changes
involving some membrane protein; those phosphorylation
changes have been usually considered to cause a decrease of
the affinity between some components of the RBCmembrane
junctional complexes [47–50] and may therefore contribute
to an alteration of the membrane structure.
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Considering that band 3 phosphorylation may have a
function in remodeling the RBC membrane to remove
noxious hemichromes [18], the present findings support the
hypothesis that erythrocytes may possess a very straight and
effective mechanism to sense the oxidative stress exerted by
low amounts of hemichromes through band 3 oxidation,
selective docking of Syk, and phosphorylation of two band
3 Tyr residues critical for assuring the local stability of the
membrane.
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